These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2231689)

  • 1. Inoculation of Macaca fascicularis with simian immunodeficiency virus, SIVmne immunologic, serologic, and pathologic changes.
    Kuller L; Morton WR; Benveniste RE; Tsai CC; Clark EA; Gale MJ; Hu SL; Thouless ME; Katze MG
    J Med Primatol; 1990; 19(3-4):367-80. PubMed ID: 2231689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.
    Hu SL; Travis BM; Stallard V; Abrams K; Misher L; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1489-94. PubMed ID: 1466988
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160.
    Hu SL; Stallard V; Abrams K; Barber GN; Kuller L; Langlois AJ; Morton WR; Benveniste RE
    J Med Primatol; 1993; 22(2-3):92-9. PubMed ID: 8411113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.
    Hu SL; Abrams K; Barber GN; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR; Benveniste RE
    Science; 1992 Jan; 255(5043):456-9. PubMed ID: 1531159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5).
    Hulskotte EG; Geretti AM; Siebelink KH; van Amerongen G; Cranage MP; Rud EW; Norley SG; de Vries P; Osterhaus AD
    J Virol; 1995 Oct; 69(10):6289-96. PubMed ID: 7666529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.
    Hu SL; Abrams K; Misher L; Stallard V; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR; Benveniste RE
    J Med Primatol; 1992; 21(2-3):119-25. PubMed ID: 1433262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrarectal inoculation of macaques by the simian immunodeficiency virus, SIVmne E11S: CD4+ depletion and AIDS.
    Kuller L; Benveniste RE; Tsai CC; Clark EA; Polacino P; Watanabe R; Overbaugh J; Katze MG; Morton WR
    J Med Primatol; 1994 Sep; 23(7):397-409. PubMed ID: 7731030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectivity and pathogenesis of titered dosages of simian immunodeficiency virus experimentally inoculated into longtailed macaques (Macaca fascicularis).
    Tsai CC; Follis KE; Grant RF; Nolte RE; Wu H; Benveniste RE
    Lab Anim Sci; 1993 Oct; 43(5):411-6. PubMed ID: 8277718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.
    Schlienger K; Montefiori DC; Mancini M; Rivière Y; Tiollais P; Michel ML
    J Virol; 1994 Oct; 68(10):6578-88. PubMed ID: 7521918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection.
    Hu SL; Polacino P; Stallard V; Klaniecki J; Pennathur S; Travis BM; Misher L; Kornas H; Langlois AJ; Morton WR; Benveniste RE
    Immunol Lett; 1996 Jun; 51(1-2):115-9. PubMed ID: 8811354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of AZT and PMEA treatment against acute SIVmne infection in macaques.
    Tsai CC; Follis KE; Grant R; Sabo A; Nolte R; Bartz C; Bischofberger N; Benveniste R
    J Med Primatol; 1994; 23(2-3):175-83. PubMed ID: 7966233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The appearance of escape variants in vivo does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus.
    Almond N; Jenkins A; Jones S; Arnold C; Silvera P; Kent K; Mills KHG; Stott EJ
    J Gen Virol; 1999 Sep; 80 ( Pt 9)():2375-2382. PubMed ID: 10501490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.
    Benson J; Chougnet C; Robert-Guroff M; Montefiori D; Markham P; Shearer G; Gallo RC; Cranage M; Paoletti E; Limbach K; Venzon D; Tartaglia J; Franchini G
    J Virol; 1998 May; 72(5):4170-82. PubMed ID: 9557706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
    Ourmanov I; Brown CR; Moss B; Carroll M; Wyatt L; Pletneva L; Goldstein S; Venzon D; Hirsch VM
    J Virol; 2000 Mar; 74(6):2740-51. PubMed ID: 10684290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines.
    Panicali DL; Mazzara G; Sullivan JL; Hesselton R; Shen L; Letvin N; Daniel M; Desrosiers R; Stott EJ
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1449. PubMed ID: 1466979
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxic T-cell response to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus.
    Gotch FM; Hovell R; Delchambre M; Silvera P; McMichael AJ
    AIDS; 1991 Mar; 5(3):317-20. PubMed ID: 2059372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
    Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
    J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells.
    Johnson PR; Montefiori DC; Goldstein S; Hamm TE; Zhou J; Kitov S; Haigwood NL; Misher L; London WT; Gerin JL
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1501-5. PubMed ID: 1466990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.